Skip to main content
Caplight Logo









Flow Pharma, Inc.

Flow Pharma, Inc.

Private
Warrensville Heights, OhioHealthcare & Life Scienceshttps://flowpharma.com/

Last Round

Grant

May 13, 2020

Total Funding Raised

$1.65M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Flow Pharma, Inc. is a biotechnology company that develops T-cell based vaccine delivery platforms and immunotherapies for the treatment and prevention of cancer and viral diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

immunotherapyvaccine platformneoantigenprecision medicinedrug discoveryAI drug discoveryin silico drug designbiotechnologybiodefenseSBIRSTTRpersonalized medicinecomputational biologyclinical-stage biotechAI biotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flow Pharma, Inc. Comparables

Compare Flow Pharma, Inc. with similar companies based on industry and business-model similarity.

Flow Pharma, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gritstone bio
79%
PDS Biotechnology Corp
77%
PathoVax LLC
73%

Flow Pharma, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 13, 2020
SeedSep 25, 2018

Key People

Founding team and executive leadership

Reid Rubsamen

Founder CEO Board Member

Founding Team

Flow Pharma, Inc. Investors

Notable investors and investment history

Flow Pharma, Inc. investors
InvestorRounds
United States Department of DefenseGrant
Button CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 31% MoM, reaching 2.2K.

  • Jul 28, 2026

    Monthly visitors increased 140% MoM.

Flow Pharma, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Flow Pharma, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Flow Pharma, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersWarrensville Heights, Ohio
Employee Range9
Year Founded1999
Last FundingMay 13, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?